Modular Medical Announces Next-Generation Pivot Insulin Pump at ADCES and Introduction of Level Ex Gamified Training Collaboration
Modular Medical (NASDAQ:MODD) announced its participation at the ADCES Conference in Phoenix, where it will showcase its next-generation Pivot patch pump. The company plans to file for FDA clearance of the Pivot pump in October 2025.
In a significant development, MODD is collaborating with Level Ex to develop gamified training modules for the Pivot pump. Level Ex, known for creating the diabetes management game 'Level One', will integrate pump training into their platform. The training modules are expected to launch alongside the product in 2026.
The initiative aims to address pump adoption barriers through gamified learning, making diabetes management more accessible and user-friendly for "almost-pumpers". A preview trailer of the gameplay is available on Modular Medical's website.
Modular Medical (NASDAQ:MODD) ha annunciato la sua partecipazione alla conferenza ADCES a Phoenix, dove presenterà il suo nuovo Pump Pivot di ultima generazione. L'azienda prevede di richiedere l'approvazione FDA per il Pivot pump entro ottobre 2025.
In un importante sviluppo, MODD sta collaborando con Level Ex per sviluppare moduli di formazione gamificati per il Pivot pump. Level Ex, noto per il gioco di gestione del diabete 'Level One', integrerà l'addestramento alla pompa nella propria piattaforma. I moduli di formazione dovrebbero essere lanciati insieme al prodotto nel 2026.
L'iniziativa mira a superare le barriere all'adozione della pompa attraverso l'apprendimento gamificato, rendendo la gestione del diabete più accessibile e intuitiva per gli "quasi utilizzatori" di pompe. Un trailer di anteprima del gameplay è disponibile sul sito di Modular Medical.
Modular Medical (NASDAQ:MODD) anunció su participación en la conferencia ADCES en Phoenix, donde presentará su bomba de parche Pivot de próxima generación. La compañía planea solicitar la aprobación de la FDA para la bomba Pivot en octubre de 2025.
En un desarrollo importante, MODD está colaborando con Level Ex para desarrollar módulos de entrenamiento gamificados para la bomba Pivot. Level Ex, conocido por crear el juego de manejo de la diabetes 'Level One', integrará el entrenamiento de la bomba en su plataforma. Se espera que los módulos de entrenamiento se lancen junto con el producto en 2026.
La iniciativa busca superar las barreras para la adopción de bombas mediante el aprendizaje gamificado, haciendo que el manejo de la diabetes sea más accesible y amigable para los "casi usuarios" de bombas. Un tráiler de vista previa del juego está disponible en el sitio web de Modular Medical.
Modular Medical (NASDAQ:MODD)는 피닉스에서 열리는 ADCES 컨퍼런스에 참여하여 차세대 Pivot 패치 펌프를 선보일 예정입니다. 회사는 2025년 10월에 Pivot 펌프에 대한 FDA 승인을 신청할 계획입니다.
중요한 발전으로 MODD는 Level Ex와 협력하여 Pivot 펌프용 게임화된 교육 모듈을 개발하고 있습니다. 당뇨병 관리 게임 'Level One'으로 알려진 Level Ex는 펌프 교육을 자사 플랫폼에 통합할 예정이며, 교육 모듈은 2026년 제품 출시와 함께 공개될 예정입니다.
이 이니셔티브는 게임화된 학습을 통해 펌프 채택의 장벽을 해소하고, '거의 펌프 사용자'들을 위해 당뇨병 관리를 보다 접근하기 쉽고 사용자 친화적으로 만드는 것을 목표로 합니다. 게임 플레이 미리보기 트레일러는 Modular Medical 웹사이트에서 확인할 수 있습니다.
Modular Medical (NASDAQ:MODD) a annoncé sa participation à la conférence ADCES à Phoenix, où elle présentera sa pompe patch Pivot de nouvelle génération. L'entreprise prévoit de déposer une demande d'autorisation FDA pour la pompe Pivot en octobre 2025.
Dans une avancée majeure, MODD collabore avec Level Ex pour développer des modules de formation gamifiés pour la pompe Pivot. Level Ex, connu pour avoir créé le jeu de gestion du diabète 'Level One', intégrera la formation à la pompe dans sa plateforme. Les modules de formation devraient être lancés en même temps que le produit en 2026.
Cette initiative vise à lever les obstacles à l'adoption de la pompe grâce à l'apprentissage gamifié, rendant la gestion du diabète plus accessible et conviviale pour les « presque utilisateurs » de pompe. Une bande-annonce de présentation du gameplay est disponible sur le site de Modular Medical.
Modular Medical (NASDAQ:MODD) gab seine Teilnahme an der ADCES-Konferenz in Phoenix bekannt, wo das Unternehmen seine nächste Generation der Pivot Patch Pumpe präsentieren wird. Die Firma plant, die FDA-Zulassung für die Pivot Pumpe im Oktober 2025 zu beantragen.
In einer bedeutenden Entwicklung arbeitet MODD mit Level Ex zusammen, um gamifizierte Trainingsmodule für die Pivot Pumpe zu entwickeln. Level Ex, bekannt für das Diabetes-Management-Spiel 'Level One', wird das Pumpentraining in seine Plattform integrieren. Die Trainingsmodule sollen zusammen mit dem Produkt im Jahr 2026 veröffentlicht werden.
Die Initiative zielt darauf ab, Barrieren bei der Pumpenakzeptanz durch gamifiziertes Lernen abzubauen und das Diabetesmanagement für „Fast-Pumpen-Anwender“ zugänglicher und benutzerfreundlicher zu gestalten. Ein Vorschau-Trailer des Gameplays ist auf der Website von Modular Medical verfügbar.
- Partnership with Level Ex to develop gamified training modules, potentially improving user adoption and education
- Planned FDA clearance submission for next-generation Pivot patch pump in October 2025
- Strategic focus on "almost-pumpers" market with user-friendly and affordable design
- First FDA-cleared patch pump specifically targeting all adult "almost-pumpers"
- Product launch not expected until 2026, indicating a significant wait time
- Success dependent on FDA clearance and market acceptance
- Complexity and technology support remain key barriers to pump adoption
Insights
Modular Medical's upcoming Pivot insulin pump and gamified training tool target barriers to adoption with a potentially market-expanding approach.
Modular Medical is positioning its next-generation tubeless Pivot patch pump to address a critical gap in the diabetes management market by specifically targeting "almost-pumpers" - individuals who could benefit from pump therapy but haven't adopted it due to complexity or cost barriers. The company's planned FDA 510(k) submission in October 2025 represents a significant milestone in their commercialization timeline, with launch expected in 2026.
The collaboration with Level Ex to develop gamified training modules is particularly noteworthy. Level Ex, which developed the diabetes management game Level One (endorsed by Breakthrough T1D), brings valuable expertise in medical gamification. Research consistently shows that gamification improves medical training effectiveness and knowledge retention - directly addressing the complexity barrier that has limited insulin pump adoption.
What makes this approach potentially disruptive is the dual focus on both hardware simplification (user-friendly pump design) and training innovation (gamified learning). The diabetes technology market has traditionally focused primarily on advanced features for experienced users rather than accessibility for new adopters. By targeting the estimated 20-30% of insulin-dependent patients who are candidates for pumps but haven't adopted them, Modular Medical is pursuing an underserved segment with significant market potential.
For context, the insulin pump market is dominated by established players like Medtronic, Insulet (Omnipod), and Tandem. Modular Medical's approach of explicitly targeting pump-hesitant patients with simplified technology could expand the overall market rather than just competing for existing pump users - a strategy that aligns with growing healthcare emphasis on improved accessibility and patient-centered design.
-Debuting a "coming soon" campaign for tubeless Pivot patch pump
- Expects special 510(k) filing for Pivot product in October
- Will introduce first level of its gamified training application developed by Level Ex, developers of the Level One diabetes-management game
SAN DIEGO, CA / ACCESS Newswire / August 8, 2025 / Modular Medical, Inc. (Nasdaq:MODD) ("Modular Medical" or the "Company"), an insulin delivery technology company with the first FDA-cleared patch pump designed specifically to target all adult "almost-pumpers" with its user-friendly and affordable design, today announced its participation at the Association of Diabetes Care & Education Specialists ("ADCES") Conference, which is being held in Phoenix, Arizona from August 8 to August 11, 2025. With over 11,000 members, the ADCES is a national network of diabetes care and education specialists working to optimize clinical outcomes for people with diabetes.
"The ADCES conference is an ideal location for us to showcase our next-generation patch pump, branded as Pivot, for which we plan to file for U.S. Food and Drug Administration ("FDA") clearance in October 2025. Diabetes care and education specialists are crucial in offering and prescribing pumps to achieve improved clinical outcomes, and we believe they will appreciate the user-friendly design of the Pivot pump and our focus on making diabetes care simpler to learn and manage for our targeted audience of Almost Pumpers," stated Jeb Besser, CEO of Modular Medical.
Modular Medical will also showcase the first playable level of the new Pivot pump gamified training module, which is being developed by Level Ex. Level Ex (powered by Relevate) is the developer of numerous medical games, including Level One, a game designed to teach the basics of caring for diabetes. Level One is endorsed by Breakthrough T1D, a leading global type 1 diabetes research and advocacy organization.
Gamification has been proven to make medical training more effective, be more efficient for the clinician and dramatically improve retention of knowledge. Complexity, including support for technology, is a key issue in pump uptake and continues to serve as a barrier to adoption, impacting both the patient and provider.
Sam Glassenberg, CEO of Level Ex, commented "Level One is free because diabetes mastery shouldn't come with a price tag. Modular Medical is breaking barriers too - bringing pump therapy to more people through smart, accessible design. Together, we intend to make diabetes management simpler and more inclusive." Glassenberg continued, "People learn best through play - and we believe they want to learn about insulin pumps the same way. In Level One, players aren't just mastering diabetes management through gameplay - they're asking to 'play' with pumps: to explore how they work, understand their benefits, and build confidence before using them in real life. Our partnership with Modular Medical helps make that possible."
A trailer showing the gameplay is now available for viewing on the Modular Medical website (modular-medical.com) in the investor section. Modular Medical currently expects the training modules for the Pivot pump to be available coincident with the launch of the product in 2026.
Forward-Looking Statements
This press release contains forward-looking statements that are made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements are subject to risks, trends, and uncertainties that could cause actual results to be materially different from the forward-looking statements contained in this press release. including but not limited to, the timing of submission of the Pivot product for FDA clearance and commercial launch; the Company's ability to convert patients to use its pump products; the occurrence of future events or circumstances, successful development of Modular Medical's proprietary technologies, whether the market will accept Modular Medical's products and services, anticipated consumer demand for the Company's products, whether Modular Medical can successfully manufacture its products at high volumes, and general economic, and industry or political conditions in the United States or internationally, as well as other risk factors and business considerations described in Modular Medical's SEC filings, including its annual report on Form 10-K. Any forward-looking statements in this press release should be evaluated in light of these important risk factors. In addition, any forward-looking statements included in this press release represent Modular Medical's views only as of the date of its publication and should not be relied upon as representing its views as of any subsequent date. Modular Medical assumes no obligation to update these forward-looking statements, except as required by law.
About Modular Medical
Modular Medical, Inc. (Nasdaq: MODD) is a development-stage medical device company that intends to launch the next generation of insulin delivery technology. Using its patented technologies, the company seeks to eliminate the tradeoff between complexity and efficacy, thereby making top quality insulin delivery both affordable and simple to learn. Our mission is to improve access to the highest standard of glycemic control for people with diabetes taking it beyond "superusers" and providing "diabetes care for the rest of us."
Modular Medical was founded by Paul DiPerna, a seasoned medical device professional and microfluidics engineer. Prior to founding Modular Medical, Mr. DiPerna was the founder (in 2005) of Tandem Diabetes and invented and designed its t:slim insulin pump. More information is available at https://modular-medical.com.
All trademarks mentioned herein are the property of their respective owners.
CONTACT:
Jeb Besser
Chief Executive Officer
Modular Medical, Inc.
+1 (617) 399-1741
IR@modular-medical.com
SOURCE: Modular Medical, Inc.
View the original press release on ACCESS Newswire